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In systematic reviews that lack data 
amenable to meta-analysis, alternative 
synthesis methods are commonly 
used, but these methods are rarely 
reported. This lack of transparency in 
the methods can cast doubt on the 
validity of the review findings. The 
Synthesis Without Meta-analysis 
(SWiM) guideline has been developed 
to guide clear reporting in reviews of 
interventions in which alternative 
synthesis methods to meta-analysis of 
effect estimates are used. This article 
describes the development of the 
SWiM guideline for the synthesis of 
quantitative data of intervention effects 
and presents the nine SWiM reporting 
items with accompanying explanations 
and examples.
Decision makers consider systematic reviews to 
be an essential source of evidence.1 Complete and 
transparent reporting of the methods and results of 
reviews allows users to assess the validity of review 
findings. The Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA; http://www.
prisma-statement.org/) statement, consisting of a 27 
item checklist, was developed to facilitate improved 
reporting of systematic reviews.2 Extensions are 
available for different approaches to conducting 
reviews (for example, scoping reviews3), reviews 
with a particular focus (for example, harms4), and 
reviews that use specific methods (for example, 
network meta-analysis.5) However, PRISMA provides 
limited guidance on reporting certain aspects of 
the review, such as the methods for presentation 
and synthesis, and no reporting guideline exists for 
synthesis without meta-analysis of effect estimates. 
We estimate that 32% of health related systematic 
reviews of interventions do not do meta-analysis,6-8 
instead using alternative approaches to synthesis that 
typically rely on textual description of effects and are 
often referred to as narrative synthesis.9 Recent work 
highlights serious shortcomings in the reporting of 
narrative synthesis, including a lack of description of 
the methods used, lack of transparent links between 
study level data and the text reporting the synthesis 
and its conclusions, and inadequate reporting of the 
limitations of the synthesis.7 This suggests widespread 
lack of familiarity and misunderstanding around the 
requirements for transparent reporting of synthesis 
when meta-analysis is not used and indicates the need 
for a reporting guideline.
Scope of SWiM reporting guideline
This paper presents the Synthesis Without Meta-
analysis (SWiM) reporting guideline. The SWiM 
guideline is intended for use in systematic reviews 
examining the quantitative effects of interventions for 
which meta-analysis of effect estimates is not possible, 
or not appropriate, for a least some outcomes.10 
Such situations may arise when effect estimates are 
incompletely reported or because characteristics of 
studies (such as study designs, intervention types, 
or outcomes) are too diverse to yield a meaningful 
summary estimate of effect.11 In these reviews, 
alternative presentation and synthesis methods 
may be adopted, (for example, calculating summary 
statistics of intervention effect estimates, vote 
counting based on direction of effect, and combining 
P values), and SWiM provides guidance for reporting 
these methods and results.11 Specifically, the SWiM 
guideline expands guidance on “synthesis of results” 
items currently available, such as PRISMA (items 14 
and 21) and RAMESES (items 11, 14, and 15).2 12 13 
SWiM covers reporting of the key features of synthesis 
including how studies are grouped, synthesis methods 
used, presentation of data and summary text, and 
limitations of the synthesis.
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SUMMARY POINTS
Systematic reviews of health related interventions often use alternative methods 
of synthesis to meta-analysis of effect estimates, methods often described as 
“narrative synthesis”
Serious shortcomings in reviews that use “narrative synthesis” have been 
identified, including a lack of description of the methods used; unclear links 
between the included data, the synthesis, and the conclusions; and inadequate 
reporting of the limitations of the synthesis
The Synthesis Without Meta-analysis (SWiM) guideline is a nine item checklist to 
promote transparent reporting for reviews of interventions that use alternative 
synthesis methods
The SWiM items prompt users to report how studies are grouped, the 
standardised metric used for the synthesis, the synthesis method, how data are 
presented, a summary of the synthesis findings, and limitations of the synthesis
The SWiM guideline has been developed using a best practice approach, 
involving extensive consultation and formal consensus
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SWiM is not intended for use in reviews that 
synthesise qualitative data, for which reporting guide-
lines are already available, including ENTREQ for 
qualitative evidence synthesis and eMERGe for meta-
ethnography.14 15
Development of SWiM reporting guideline
A protocol for the project is available,10 and the guide-
line development was registered with the EQUATOR 
Network, after confirmation that no similar guideline 
was in development. All of the SWiM project team 
are experienced systematic reviewers, and one was 
a co-author on guidance on the conduct of narrative 
synthesis (AS).9 A project advisory group was con-
vened to provide greater diversity in expertise. The 
project advisory group included representatives from 
collaborating Cochrane review groups, the Campbell 
Collaboration, and the UK National Institute for Health 
and Care Excellence (see supplementary file 1).
The project was informed by recommendations for 
developing guidelines for reporting of health research.16 
We assessed current practice in reporting synthesis of 
effect estimates without meta-analysis and used the 
findings to devise an initial checklist of reporting items 
in consultation with the project advisory group. We 
invited 91 people, all systematic review methodologists 
or authors of reviews that synthesised results from 
studies without using meta-analysis, to participate in 
a three round Delphi exercise, with a response rate of 
48% (n=44/91) in round one, 54% (n=37/68) in round 
two, and 82% (n=32/39) in round three. The results 
were discussed at a consensus meeting of an expert 
panel (the project advisory group plus one additional 
methodological expert) (see supplementary file 1). 
After the meeting, we piloted the revised guideline to 
assess ease of use and face validity. Eight systematic 
reviewers with varying levels of experience, who had 
not been involved in the Delphi exercise, were asked 
to read and apply the guideline. We conducted short 
interviews with the pilot participants to identify any 
clarification needed in the items or their explanations. 
We subsequently revised the items and circulated 
them for comment among the expert panel, before 
finalising them. Full methodological details of the 
SWiM guideline development process are provided in 
supplementary file 1.
Synthesis without meta-analysis reporting items
We identified nine items to guide the reporting of syn-
thesis without meta-analysis. Table 1 shows these SWiM 
reporting items. An online version is available at www.
equator-network.org/reporting-guidelines. An explanation 
and elaboration for each of the reporting items is provided 
below. Examples to illustrate the reporting items and 
explanations are provided in supplementary file 2.
Item 1: grouping studies for synthesis
1a) Description
Provide a description of, and rationale for, the groups 
used in the synthesis (for example, groupings of 
interventions, population, outcomes, study design).
1a) Explanation
Methodological and clinical or conceptual diversity 
may occur (for example, owing to inclusion of diverse 
study designs, outcomes, interventions, contexts, 
populations), and it is necessary to clearly report 
how these study characteristics are grouped for the 
synthesis, along with the rationale for the groups (see 
Cochrane Handbook Chapter 317). Although reporting 
the grouping of study characteristics in all reviews 
is important, it is particularly important in reviews 
without meta-analysis, as the groupings may be less 
evident than when meta-analysis is used.
Providing the rationale, or theory of change, for 
how the intervention is expected to work and affect 
the outcome(s) will inform authors’ and review users’ 
decisions about the appropriateness and usefulness 
of the groupings. A diagram, or logic model,18 19 can 
be used to visually articulate the underlying theory of 
change used in the review. If the theory of change for the 
intervention is provided in full elsewhere (for example, 
in the protocol), this should be referenced. In Cochrane 
reviews, the rationale for the groups can be outlined in 
the section “How the intervention is expected to work.”
1b) Description
Detail and provide rationale for any changes made 
subsequent to the protocol in the groups used in the 
synthesis.
1b) Explanation
Decisions about the planned groups for the syntheses 
may need to be changed following study selection and 
data extraction. This may occur as a result of important 
variations in the population, intervention, comparison, 
and/or outcomes identified after the data are collected, 
or where limited data are available for the pre-specified 
groupings, and the groupings may need to be modified 
to facilitate synthesis (Cochrane Handbook Chapter 
220). Reporting chan ges to the planned groups, and the 
reason(s) for these, is important for transparency, as this 
allows readers to assess whether the changes may have 
been influenced by study findings. Furthermore, grouping 
at a broader level of (any or multiple) intervention, 
population, or outcome will have implications for 
the interpretation of the synthesis findings (see 
item 8).
Item 2: describe the standardised metric and 
transformation method used
Description
Describe the standardised metric for each outcome. 
Explain why the metric(s) was chosen, and describe 
any methods used to transform the intervention 
effects, as reported in the study, to the standardised 
metric, citing any methodological guidance used.
Explanation
The term “standardised metric” refers to the metric that 
is used to present intervention effects across the studies 
for the purpose of synthesis or interpretation, or both. 
Examples of standardised metrics include measures 
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of intervention effect (for example, risk ratios, odds 
ratios, risk differences, mean differences, standardised 
mean differences, ratio of means), direction of effect, or 
P values. An example of a statistical method to convert 
an odds ratio to a standardised mean difference is that 
proposed by Chinn (2000).21 For other methods and 
metrics, see Cochrane Handbook Chapter 6.22
Item 3: describe the synthesis methods
Description
Describe and justify the methods used to synthesise 
the effects for each outcome when it was not possible 
to undertake a meta-analysis of effect estimates.
Explanation
For various reasons, it may not be possible to do a meta-
analysis of effect estimates. In these circumstances, 
other synthesis methods need to be considered and 
specified. Examples include combining P values, 
calculating summary statistics of intervention effect 
estimates (for example, median, interquartile range) 
or vote counting based on direction of effect. See table 
2 for a summary of possible synthesis methods (for 
further details, see McKenzie and Brennan 201911). 
Justification should be provided for the chosen 
synthesis method.
Item 4: criteria used to prioritise results for 
summary and synthesis
Description
Where applicable, provide the criteria used, with 
supporting justification, to select particular studies, 
or a particular study, for the main synthesis or to draw 
conclusions from the synthesis (for example, based on 
study design, risk of bias assessments, directness in 
relation to the review question).
Explanation
Criteria may be used to prioritise the reporting of some 
study findings over others or to restrict the synthesis 
to a subset of studies. Examples of criteria include the 
type of study design (for example, only randomised 
trials), risk of bias assessment (for example, only 
studies at a low risk of bias), sample size, the relevance 
of the evidence (outcome, population/context, or 
intervention) pertaining to the review question, or the 
certainty of the evidence. Pre-specification of these 
criteria provides transparency as to why certain studies 
are prioritised and limits the risk of selective reporting 
of study findings.
Item 5: investigation of heterogeneity in reported 
effects
Description
State the method(s) used to examine heterogeneity in 
reported effects when it is not possible to do a meta-
analysis of effect estimates and its extensions to 
investigate heterogeneity.
Explanation
Informal methods to investigate heterogeneity in the 
findings may be considered when a formal statistical 
investigation using methods such as subgroup 
analysis and meta-regression is not possible. Infor-
Table 1 | Synthesis Without Meta-analysis (SWiM) items: SWiM is intended to complement and be used as an extension to PRISMA
SWiM reporting item Item description
Page in manuscript 
where item is reported Other*
Methods
1 Grouping studies  
for synthesis
1a) Provide a description of, and rationale for, the groups used in the synthesis  
(eg, groupings of populations, interventions, outcomes, study design)
1b) Detail and provide rationale for any changes made subsequent to the protocol in the groups 
used in the synthesis
2 Describe the standardised metric and 
transformation methods used
Describe the standardised metric for each outcome. Explain why the metric(s) was chosen and 
describe any methods used to transform the intervention effects, as reported in the study, to the 
standardised metric, citing any methodological guidance consulted
3 Describe the synthesis methods Describe and justify the methods used to synthesise the effects for each outcome  
when it was not possible to undertake a meta-analysis of effect estimates
4 Criteria used to prioritise results for  
summary and synthesis
Where applicable, provide the criteria used, with supporting justification, to select the particular 
studies, or a particular study, for the main synthesis or to draw conclusions from the synthesis 
(eg, based on study design, risk of bias assessments, directness in relation to the review question)
5 Investigation of heterogeneity  
in reported effects
State the method(s) used to examine heterogeneity in reported effects when it was not possible 
to undertake a meta-analysis of effect estimates and its extensions to investigate heterogeneity
6 Certainty of evidence Describe the methods used to assess the certainty of the synthesis findings
7 Data presentation methods Describe the graphical and tabular methods used to present the effects  
(eg, tables, forest plots, harvest plots) 
Specify key study characteristics (eg, study design, risk of bias) used to order the studies, in the 
text and any tables or graphs, clearly referencing the studies included
Results
8 Reporting results For each comparison and outcome, provide a description of the synthesised findings and the 
certainty of the findings. Describe the result in language that is consistent with the question the 
synthesis addresses, and indicate which studies contribute to the synthesis
Discussion
9 Limitations of the synthesis Report the limitations of the synthesis methods used and/or the groupings used in the synthesis 
and how these affect the conclusions that can be drawn in relation to the original review question
PRISMA=Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
*If the information is not provided in the systematic review, give details of where this information is available (eg, protocol, other published papers (provide citation details), or website (provide 
the URL)).
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mal methods could involve ordering tables or struc-
turing figures by hypothesised modifiers such as 
methodological characteristics (for example, study 
design), subpopulations (for example, sex, age), 
intervention components, and/or contextual/setting 
factors (see Cochrane Handbook Chapter 1211). The 
methods used and justification for the chosen methods 
should be reported. Investigations of heterogeneity 
should be limited, as they are rarely definitive; this 
is more likely to be the case when informal methods 
are used. It should also be noted if the investigation of 
heterogeneity was not pre-specified.
Item 6: certainty of evidence
Description
Describe the methods used to assess the certainty of 
the synthesis findings.
Explanation
The assessment of the certainty of the evidence should 
aim to take into consideration the precision of the 
synthesis finding (confidence interval if available), the 
number of studies and participants, the consistency 
of effects across studies, the risk of bias of the studies, 
how directly the included studies address the planned 
question (directness), and the risk of publication bias. 
GRADE (Grading of Recommendations, Assessment, 
Development and Evaluations) is the most widely 
used framework for assessing certainty (Cochrane 
Handbook Chapter 1423). However, depending on the 
synthesis method used, assessing some domains (for 
example, consistency of effects when vote counting is 
undertaken) may be difficult.
Item 7: data presentation methods
Description
Describe the graphical and tabular methods used to 
present the effects (for example, tables, forest plots, 
harvest plots).
Specify key study characteristics (for example, study 
design, risk of bias) used to order the studies, in the 
text and any tables or graphs, clearly referencing the 
studies included
Explanation
Study findings presented in tables or graphs should be 
ordered in the same way as the syntheses are reported 
in the narrative text to facilitate the comparison of 
findings from each included study. Key characteristics, 
such as study design, sample size, and risk of bias, 
which may affect interpretation of the data, should 
also be presented. Examples of visual displays include 
forest plots,24 harvest plots,25 effect direction plots,26 
albatross plots,27 bubble plots,28 and box and whisker 
plots.29 McKenzie and Brennan (2019) provide a 
description of these plots, when they should be used, 
and their pros and cons.11
Item 8: reporting results
Description
For each comparison and outcome, provide a des-
cription of the synthesised findings and the certainty 
of the findings. Describe the result in language that is 
consistent with the question the synthesis addresses 
and indicate which studies contribute to the synthesis.
Explanation
For each comparison and outcome, a description of the 
synthesis findings should be provided, making clear 
which studies contribute to each synthesis (for example, 
listing in the text or tabulated). In describing these 
findings, authors should be clear about the nature of the 
question(s) addressed (see table 2, column 1), the metric 
and synthesis method used, the number of studies and 
participants, and the key characteristics of the included 
studies (population/settings, interventions, outcomes). 
When possible, the synthesis finding should be 
accompanied by a confidence interval. An assessment 
of the certainty of the effect should be reported. 
Results of any investigation of heterogeneity should 
be described, noting if it was not pre-planned and 
avoiding over-interpretation of the findings.
If a pre-specified logic model was used, authors may 
report any changes made to the logic model during the 
review or as a result of the review findings.30
Item 9: limitations of the synthesis
Description
Report the limitations of the synthesis methods used 
and/or the groupings used in the synthesis and how 
these affect the conclusions that can be drawn in 
relation to the original review question.
Explanation
When reporting limitations of the synthesis, factors 
to consider are the standardised metric(s) used, the 
Table 2 | Questions answered according to types of synthesis methods and types of data used
Question answered Synthesis method
Minimum data required
Estimate of 
effect Variance
Direction of 
effect
Precise  
P value
What is the common intervention effect? What is the  
average intervention effect? Which intervention, of  
multiple, is most effective? What factors modify the  
magnitude of the intervention effects?
Meta-analysis of effect estimates and extensions  
(eg, sub-group analysis, meta-regression, network  
meta-analysis)
  - -
What is the range and distribution of observed effects? Summarising effect estimates  - - -
Is there evidence of an effect in at least one study? Combining P values - -  
Is there any evidence of an effect? Vote counting based on direction of effect - -  -
Abbreviated from table 12.2.a of McKenzie and Brennan 2019.11
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synthesis method used, and any reconfiguration of the 
groups used to structure the synthesis (comparison, 
intervention, population, outcome).
The choice of metric and synthesis method will affect 
the question addressed (see table 2). For example, 
if the standardised metric is direction of effect, and 
vote counting is used, the question will ask “is there 
any evidence of an effect?” rather than “what is the 
average intervention effect?” had a random effects 
meta-analysis been used.
Limitations of the synthesis might arise from post-
protocol changes in how the synthesis was structured 
and the synthesis method selected. These changes may 
occur because of limited evidence, or incompletely 
reported outcome or effect estimates, or if different 
effect measures are used across the included studies. 
These limitations may affect the ability of the synthesis 
to answer the planned review question—for example, 
when a meta-analysis of effect estimates was planned 
but was not possible.
Discussion
The SWiM reporting guideline is intended to facilitate 
transparent reporting of the synthesis of effect estimates 
when meta-analysis is not used. The guideline relates 
specifically to transparently reporting synthesis and 
presentation methods and results, and it is likely to be 
of greatest relevance to reviews that incorporate diverse 
sources of data that are not amenable to meta-analysis. 
The SWiM guideline should be used in conjunction 
with other reporting guidelines that cover other 
aspects of the conduct of reviews, such as PRISMA.31 
We intend SWiM to be a resource for authors of reviews 
and to support journal editors and readers in assessing 
the conduct of a review and the validity of its findings.
The SWiM reporting items are intended to cover 
aspects of presentation and synthesis of study findings 
that are often left unreported when methods other 
than meta-analysis have been used.7 These include 
reporting of the synthesis structure and comparison 
groupings (items 1, 4, 5, and 6), the standardised metric 
used for the synthesis (item 2), the synthesis method 
(items 3 and 9), presentation of data (item 7), and a 
summary of the synthesis findings that is clearly linked 
to supporting data (item 8). Although the SWiM items 
have been developed specifically for the many reviews 
that do not include meta-analysis, SWiM promotes the 
core principles needed for transparent reporting of all 
synthesis methods including meta-analysis. Therefore, 
the SWiM items are relevant when reporting synthesis 
of quantitative effect data regardless of the method 
used.
Reporting guidelines are sometimes interpreted as 
providing guidance on conduct or used to assess the 
quality of a study or review; this is not an appropriate 
application of a reporting guideline, and SWiM should 
not be used to guide the conduct of the synthesis. 
For guidance on how to conduct synthesis using the 
methods referred to in SWiM, we direct readers to 
the second edition of the Cochrane Handbook for 
Systematic Reviews of Interventions, specifically 
chapter 12.11 Although an overlap inevitably exists 
between reporting and conduct, the SWiM reporting 
guideline is not intended to be prescriptive about 
choice of methods, and the level of detail for each item 
should be appropriate. For example, investigation of 
heterogeneity (item 5) may not always be necessary 
or useful. In relation to SWiM, we anticipate that the 
forthcoming update of PRISMA will include new items 
covering a broader range of synthesis methods,32 but 
it will not provide detailed guidance and examples on 
synthesis without meta-analysis.
The SWiM reporting guideline emerged from a project 
aiming to improve the transparency and conduct of 
narrative synthesis (ICONS-Quant: Improving the 
CONduct and reporting of Narrative Synthesis).10 
Avoidance of the term “narrative synthesis” in SWiM 
is a deliberate move to promote clarity in the methods 
used in reviews in which the synthesis does not rely 
on meta-analysis. The use of narrative is ubiquitous 
across all research and can serve a valuable purpose 
in the development of a coherent story from diverse 
data.33 34 However, within the field of evidence synthe-
sis, narrative approaches to synthesis of quantitative 
effect estimates are characterised by a lack of trans-
parency, making assessment of the validity of their 
findings difficult.7 Together with the recently published 
guidance on conduct of alternative methods of 
synthesis,11 the SWiM guideline aims to improve the 
transparency of, and subsequently trust in, the many 
reviews that synthesise quantitative data without meta-
analysis, particularly for reviews of intervention effects.
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